|
|
News Breaks | | | | February 20, 2013 | | 07:05 EDT |  | COV | Covidien completes patient enrollment in Iliac stent clinical study series
Covidien announced the completion of patient enrollment in its iliac stent clinical study series. The series is composed of two prospective, multinational, multicenter studies - VISIBILITY Iliac and DURABILITY Iliac. Each study is designed to evaluate the safety and effectiveness of using either balloon expandable or self-expanding stents to treat peripheral arterial disease in the common iliac and external iliac arteries. Primary effectiveness of the stents and incidence of major adverse events will be evaluated through nine months, and patients in the study will be followed for a total of three years. | |
|
News For COV From The Last 14 Days Check below for free stories on COV the last two weeks. |
|
|
| June 17, 2013 | | 07:02 EDT | | COV | Covidien announces publication of final results of Pipeline study
Covidien announced that the final results of the PUFs, Pipeline for Uncoilable or Failed Aneurysms, clinical study of its Pipeline embolization device have been published in the June issue of Radiology, the official peer-reviewed medical journal of the Radiological Society of North America. The Pipeline device met the trial’s primary endpoints for both effectiveness and safety. Based on these data, the Pipeline device was approved by the U.S. Food and Drug Administration on April 6, 2011. | |
|
|
|
|
|
|
